Artiva Biotherapeutics, Inc.
ARTVNasdaqCIK 1817241HealthcareFiscal year ends Dec 31
Reports and events: 48 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2708:30 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0001193125-26-432806 |
| 2026-09-1116:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-389308 |
| 2026-08-0616:12 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-338029 |
| 2026-08-0616:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-337986 |
| 2026-08-0316:08 ET | DEF 14A | Proxy statementPeriod 2026-09-08 | 0001193125-26-330563 |
| 2026-07-2321:23 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-26-000203 |
| 2026-07-2217:15 ET | 8-K | 8.01 Other events | 0001193125-26-312560 |
| 2026-06-1519:37 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-26-000173 |
| 2026-05-2816:38 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001931382-26-000009 |
| 2026-05-1908:07 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-229714 |
| 2026-05-1317:47 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-26-000129 |
| 2026-05-0816:24 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-214711 |
| 2026-05-0806:40 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-213242 |
| 2026-05-0806:37 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-213239 |
| 2026-04-3016:01 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001193125-26-197115 |
| 2026-03-1016:09 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-100135 |
| 2026-03-1016:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-100131 |
| 2026-02-2417:14 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-067509 |
| 2026-02-1917:20 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-059716 |
| 2025-12-1217:23 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-317784 |
| 2025-11-1207:22 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-275902 |
| 2025-11-1207:08 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-275872 |
| 2025-11-1207:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-275867 |
| 2025-08-0616:13 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-104045 |
| 2025-08-0616:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104028 |
| 2025-06-2516:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-089942 |
| 2025-05-0808:06 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-066421 |
| 2025-05-0808:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066416 |
| 2025-04-2921:34 ET | DEF 14A | Proxy statementPeriod 2025-06-24 | 0001193125-25-101364 |
| 2025-03-2416:09 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-043837 |
| 2025-03-2416:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-043828 |
| 2025-01-2916:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-010481 |
| 2024-11-1216:10 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-125382 |
| 2024-11-1216:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-125359 |
| 2024-10-2216:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-241059 |
| 2024-09-0316:18 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-096378 |
| 2024-08-2916:18 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001193125-24-209924 |
| 2024-08-2916:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-209920 |
| 2024-07-2916:29 ET | SC 13D | Ownership report, active investor | 0001104659-24-083555 |
| 2024-07-2916:15 ET | SC 13D | Ownership report, active investor | 0001193125-24-187576 |
| 2024-07-2216:19 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-182231 |
| 2024-07-1506:07 ET | S-1/A | Registration statement, amended | 0001193125-24-178806 |
| 2024-06-2816:04 ET | S-1 | Registration statement | 0001193125-24-172230 |
| 2022-06-0617:29 ET | S-1/A | Registration statement, amended | 0001193125-22-168492 |
| 2022-03-0716:28 ET | S-1/A | Registration statement, amended | 0001193125-22-068001 |
| 2022-01-2117:29 ET | S-1/A | Registration statement, amended | 0001193125-22-014926 |
| 2021-12-1621:49 ET | S-1/A | Registration statement, amended | 0001193125-21-358277 |
| 2021-04-0817:16 ET | S-1 | Registration statement | 0001193125-21-110347 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 08:31 ET. Listed shows no prices and gives no investment advice.